This week, Hackaday’s Elliot Williams and Kristina Panos met up over coffee to bring you the latest news, mystery sound ...

Protalix BioTherapeutics, Inc. (NYSE:PLX) announced a collaboration with the Germany-based Secarna Pharmaceuticals to develop novel antisense oligonucleotide (ASO) therapies using Secarna’s ...

Protalix BioTherapeutics, Inc. (NYSE:PLX) announced 3Q:25 financial and operational results in a November 13th, 2025, press release and in its Form 10-Q filing. The reports were followed by a ...

Forbes contributors publish independent expert analyses and insights. Chief Analyst & CEO, NAND Research. Qualcomm, a company built on selling chips to companies like Samsung and Apple in volumes of ...

Qualcomm Technologies Inc. today announced plans to acquire Arduino S.r.l., an Italian company that develops open-source single-board computers. The terms of the deal were not disclosed. Arduino’s ...

Qualcomm announced Tuesday it is buying Arduino, an Italian developer of tiny computers used worldwide by artists and makers for interactive projects. The San Diego-based company’s Qualcomm ...

SAN FRANCISCO, Oct 7 (Reuters) - Qualcomm (QCOM.O), opens new tab on Tuesday said it has acquired Arduino, an Italian not-for-profit firm that makes hardware and software for developing prototypes of ...

Smartphone processor and modem maker Qualcomm is acquiring Arduino, the Italian company known mainly for its open source ecosystem of microcontrollers and the software that makes them function. In its ...

Qualcomm is acquiring Arduino in a move aimed at enhancing the company's portfolio of edge technologies and products, following several recent product unveilings by the company last month. The company ...

DEER PARK, N.Y.--(BUSINESS WIRE)--Luxium Solutions, LLC (“Luxium” or the “Company”), a worldwide technology leader and provider of high-performance crystals used in photonics and radiation detection ...

Protalix BioTherapeutics uses a plant-cell approach with ProCellEx. This has given it two approved ERTs plus PRX-115 and PRX-119. Its main focus is on a growing rare-disease pipeline. The main value ...